CEO Michael Kauffman sold $344K of Karyopharm Therapeutics Inc.

Sold$343,621

$17.18Price

20,000Shares

−2%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Tue, Feb 11. Filed Wed, Feb 12, 11:20 AM ET, during the session. Not investment advice.